Shield Therapeutics plc (STX.L)
GBp 2.75
(0.0%)
GBp 2.75
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -29.94 Million | -18.24 Million | -16.73 Million | -1.4 Million | -4.06 Million | -178 Thousand |
| Net Income | -26.78 Million | -40.44 Million | -19.33 Million | -2.63 Million | -8.8 Million | -1.79 Million |
| Depreciation & Amortization | 861.58 Thousand | 2.36 Million | 2.2 Million | 2.7 Million | 2.62 Million | 2.35 Million |
| Deferred income taxes | - | - | 1.75 Million | 644 Thousand | 1.07 Million | -1.48 Million |
| Stock-based compensation | 875 Thousand | 912 Thousand | 1.33 Million | 1.05 Million | 456 Thousand | 1.01 Million |
| Change in working capital | -5.65 Million | 4.7 Million | -2 Million | -2.62 Million | 553 Thousand | -255 Thousand |
| Other non-cash items | 8.61 Million | 14.38 Million | -353 Thousand | -268 Thousand | 31 Thousand | -15 Thousand |
| Investing Cash Flow | -2.37 Million | -1.69 Million | -2.05 Million | -20 Thousand | -1.36 Million | -3.34 Million |
| Investments in PPE | -2.37 Million | -1.89 Million | -2.06 Million | -23 Thousand | -1.38 Million | -3.34 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.19 Million | 200 Thousand | 13 Thousand | 3000.00 | 18 Thousand | - |
| Financing Cash Flow | 40.43 Million | 7.7 Million | 27.58 Million | -47 Thousand | -203 Thousand | -344 Thousand |
| Debt repayment | -15.64 Million | -7.52 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -82 Thousand | - | - | - | - |
| Common Stock Issuance | 21.57 Million | 87 Thousand | 27.7 Million | 6000.00 | 26 Thousand | - |
| Other Financing Activities | 3.66 Million | 22.76 Million | -121 Thousand | -53 Thousand | -229 Thousand | - |
| Accounts receivables | -5.63 Million | -2.31 Million | -2.87 Million | -264 Thousand | 681 Thousand | 541 Thousand |
| Accounts payables | 1.53 Million | 6.03 Million | 1.98 Million | -2.07 Million | 999 Thousand | -953 Thousand |
| Inventory | -1.16 Million | 178 Thousand | -256 Thousand | -431 Thousand | -839 Thousand | 16 Thousand |
| Other working capital | -384.53 Thousand | 811 Thousand | -857 Thousand | 148 Thousand | -288 Thousand | -271 Thousand |
| Cash at beginning of period | 2.82 Million | 12.11 Million | 2.94 Million | 4.14 Million | 9.77 Million | 13.29 Million |
| Cash at end of period | 10.94 Million | 2.82 Million | 12.11 Million | 2.94 Million | 4.14 Million | 9.77 Million |
| Capital Expenditure | -2.37 Million | -1.89 Million | -2.06 Million | -23 Thousand | -1.38 Million | -3.34 Million |
| Effect of forex changes on cash | 446 Thousand | 2.93 Million | 382 Thousand | 266 Thousand | - | - |
| Net cash flow / Change in cash | 8.12 Million | -9.29 Million | 9.17 Million | -1.2 Million | -5.63 Million | -3.52 Million |
| Free Cash Flow | -32.31 Million | -20.14 Million | -18.8 Million | -1.42 Million | -5.45 Million | -3.52 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.23 Million | -26.78 Million | -16.51 Million | -10.22 Million | -28.66 Million | -40.44 Million |
| Depreciation & Amortization | 475.18 Thousand | 861.58 Thousand | 436.54 Thousand | 424.91 Thousand | 1.27 Million | 2.36 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 875 Thousand | - | - | - | 912 Thousand |
| Change in working capital | 7.2 Million | -5.65 Million | 1.73 Million | -7.34 Million | 6.67 Million | 4.7 Million |
| Other non-cash items | -856.27 Thousand | 8.61 Million | 180.21 Thousand | 8.53 Million | 9.42 Million | 14.38 Million |
| Investing Cash Flow | -1.59 Million | -2.37 Million | -1.01 Million | -1.33 Million | -592 Thousand | -1.69 Million |
| Investments in PPE | -800.13 Thousand | -2.37 Million | -1.01 Million | -1.33 Million | -592 Thousand | -1.89 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -790.64 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 200 Thousand |
| Financing Cash Flow | -92.5 Thousand | 40.43 Million | 15.68 Million | 24.43 Million | 7.28 Million | 7.7 Million |
| Debt repayment | - | -15.64 Million | -7.41 Million | -8.1 Million | -7.52 Million | -7.52 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -82 Thousand |
| Common Stock Issuance | - | 21.57 Million | 21.4 Million | - | 30 Thousand | 87 Thousand |
| Other Financing Activities | -92.5 Thousand | 3.66 Million | -12.72 Million | 16.35 Million | -145 Thousand | 22.76 Million |
| Accounts receivables | -1.5 Million | -5.63 Million | -2.66 Million | -2.92 Million | -1.19 Million | -2.31 Million |
| Accounts payables | 5.25 Million | 1.53 Million | 4.24 Million | -2.72 Million | 5.98 Million | 6.03 Million |
| Inventory | -657.82 Thousand | -1.16 Million | -393.38 Thousand | -760.63 Thousand | -34 Thousand | 178 Thousand |
| Other working capital | 4.12 Million | -384.53 Thousand | 544.58 Thousand | -926.06 Thousand | 1.91 Million | 811 Thousand |
| Cash at beginning of period | 10.94 Million | 2.82 Million | 10.69 Million | 2.82 Million | 2.4 Million | 12.11 Million |
| Cash at end of period | 6.4 Million | 10.94 Million | 10.94 Million | 10.69 Million | 2.82 Million | 2.82 Million |
| Capital Expenditure | -800.13 Thousand | -2.37 Million | -1.01 Million | -1.33 Million | -592 Thousand | -1.89 Million |
| Effect of forex changes on cash | - | 446 Thousand | - | 641.45 Thousand | 2.81 Million | 2.93 Million |
| Net cash flow / Change in cash | -4.53 Million | 8.12 Million | 248.75 Thousand | 7.87 Million | 417 Thousand | -9.29 Million |
| Free Cash Flow | -4.07 Million | -32.31 Million | -14.85 Million | -17.2 Million | -9.68 Million | -20.14 Million |
6091
QUCOF
1408
SPTJF
AMLH
SYSTMTXC